On May 9, 2025, the Tianjin Municipal Administration for Market Regulation (“Tianjin AMR”) announced administrative penalties against four manufacturers of dexamethasone sodium phosphate (“DSP”) active pharmaceutical ingredients (“APIs”) for engaging in a horizontal monopoly agreement….
By: Dacheng
By: Dacheng